Gilbert, AZ, November 25, 2014 – WCP, a privately held specialty pharmaceutical company focused in women’s health, today announced that it completed the acquisition of Edwards, a privately held specialty pharmaceutical company located in Ripley, Mississippi. Edwards’s markets OTC cough and cold products along with a branded prescription Urinary Antiseptic/Anti-Spasmodic product.
The acquisition will result in the strategic expansion of WCP into the fast-growing market of Urology. With the Edwards acquisition, WCP will increase and further diversify its presence in the specialty pharmaceuticals market and accelerate growth in both women’s health and urology.
The companies together will now have a combined nationwide sales force of 60 field sales representatives that will focus their promotional efforts on the high volume, office-based OB/GYNs, Urologists and select GPs/FPs.